5ts8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (15:42, 6 March 2024) (edit) (undo)
 
Line 3: Line 3:
<StructureSection load='5ts8' size='340' side='right'caption='[[5ts8]], [[Resolution|resolution]] 1.45&Aring;' scene=''>
<StructureSection load='5ts8' size='340' side='right'caption='[[5ts8]], [[Resolution|resolution]] 1.45&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[5ts8]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TS8 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5TS8 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[5ts8]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Zea_mays Zea mays]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TS8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5TS8 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7M0:5,6-DIBROMOBENZOTRIAZOLE'>7M0</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=BME:BETA-MERCAPTOETHANOL'>BME</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=TLA:L(+)-TARTARIC+ACID'>TLA</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.45&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4rkl|4rkl]], [[1j91|1j91]], [[1daw|1daw]], [[4kwp|4kwp]], [[1p5e|1p5e]], [[2oxy|2oxy]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7M0:5,6-DIBROMOBENZOTRIAZOLE'>7M0</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=BME:BETA-MERCAPTOETHANOL'>BME</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=TLA:L(+)-TARTARIC+ACID'>TLA</scene></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5ts8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ts8 OCA], [http://pdbe.org/5ts8 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5ts8 RCSB], [http://www.ebi.ac.uk/pdbsum/5ts8 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5ts8 ProSAT]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ts8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ts8 OCA], [https://pdbe.org/5ts8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ts8 RCSB], [https://www.ebi.ac.uk/pdbsum/5ts8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ts8 ProSAT]</span></td></tr>
</table>
</table>
-
<div style="background-color:#fffaf0;">
+
== Function ==
-
== Publication Abstract from PubMed ==
+
[https://www.uniprot.org/uniprot/CSK2A_MAIZE CSK2A_MAIZE] Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site.
-
The interaction of human CK2alpha (hCK2alpha) with nine halogenated benzotriazoles, TBBt and its analogues representing all possible patterns of halogenation on the benzene ring of benzotriazole, was studied by biophysical methods. Thermal stability of protein-ligand complexes, monitored by calorimetric (DSC) and optical (DSF) methods, showed that the increase in the mid-point temperature for unfolding of protein-ligand complexes (i.e. potency of ligand binding to hCK2alpha) follow the inhibitory activities determined by biochemical assays. The dissociation constant for the ATP-hCK2alpha complex was estimated with the aid of microscale thermophoresis (MST) as 4.3+/-1.8 muM, and MST-derived dissociation constants determined for halogenated benzotriazoles, when converted according to known ATP concentrations, perfectly reconstruct IC50 values determined by the biochemical assays. Ligand-dependent quenching of tyrosine fluorescence, together with molecular modeling and DSC-derived heats of unfolding, support the hypothesis that halogenated benzotriazoles bind in at least two alternative orientations, and those that are efficient hCK2alpha inhibitors bind in the orientation which TBBt adopts in its complex with maize CK2alpha. DSC-derived apparent heat for ligand binding (DeltaDeltaHbind) is driven by intermolecular electrostatic interactions between Lys68 and the triazole ring of the ligand, as indicated by a good correlation between DeltaDeltaHbind and ligand pKa. Overall results, additionally supported by molecular modeling, confirm that a balance of hydrophobic and electrostatic interactions contribute predominantly (~40 kJ/mol), relative to possible intermolecular halogen/hydrogen bonding (less than 10 kJ/mol), in binding of halogenated benzotriazoles to the ATP-binding site of hCK2alpha. This article is part of a Special Issue entitled: Inhibitors of Protein Kinases.
+
-
 
+
-
Thermodynamics parameters for binding of halogenated benzotriazole inhibitors of human protein kinase CK2alpha.,Winiewska M, Kucinska K, Makowska M, Poznanski J, Shugar D Biochim Biophys Acta. 2015 Oct;1854(10 Pt B):1708-17. doi:, 10.1016/j.bbapap.2015.04.004. Epub 2015 Apr 17. PMID:25891901<ref>PMID:25891901</ref>
+
-
 
+
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
+
-
</div>
+
-
<div class="pdbe-citations 5ts8" style="background-color:#fffaf0;"></div>
+
==See Also==
==See Also==
*[[Casein kinase 3D structures|Casein kinase 3D structures]]
*[[Casein kinase 3D structures|Casein kinase 3D structures]]
-
== References ==
 
-
<references/>
 
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Bochtler, M]]
+
[[Category: Zea mays]]
-
[[Category: Czapinska, H]]
+
[[Category: Bochtler M]]
-
[[Category: Kucinska, K]]
+
[[Category: Czapinska H]]
-
[[Category: Piasecka, A]]
+
[[Category: Kucinska K]]
-
[[Category: Poznanski, J]]
+
[[Category: Piasecka A]]
-
[[Category: Winiewska, M]]
+
[[Category: Poznanski J]]
-
[[Category: Bromo-benzotriazole]]
+
[[Category: Winiewska M]]
-
[[Category: Casein kinase 2]]
+
-
[[Category: Ck2]]
+
-
[[Category: Halogen bond]]
+
-
[[Category: Inhibitor]]
+
-
[[Category: Transferase-transferase inhibitor complex]]
+
-
[[Category: Transferase/transferase inhibitor]]
+

Current revision

Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE

PDB ID 5ts8

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools